Results 31 to 40 of about 2,152,109 (243)

Branch Retinal Vein Occlusion, Macular Ischemia, and Intravitreal Anti-VEGF Therapy

Case Reports in Ophthalmology, 2017
Purpose: To report a case with ischemic macular edema (ME) due to an acute branch retinal vein occlusion (BRVO) which was treated with repeated intravitreal anti-VEGF injections. Methods: Retrospective case presentation.
Thomas Bertelmann, Hans Ulrich Frank, Hendrik Ansgar Fuchs, Nicolas Feltgen   +3 more
doaj   +1 more source

Evaluation of long-term intravitreal anti-vascular endothelial growth factor injections on renal function in patients with and without diabetic kidney disease

BMC Nephrology, 2019
Background Administering anti-vascular endothelial growth factor (anti-VEGF) by intraocular injection has been shown to have a safe systemic profile. Nevertheless, incidents of acute kidney injury following anti-VEGF injection have been reported.
Rachael Ann O’Neill, Patrick Gallagher, Tricia Douglas, Julie-Anne Little, Alexander Peter Maxwell, Giuliana Silvestri, Gareth McKay   +6 more
doaj   +1 more source

Factors Influencing Visual Acuity in Patients with Active Subfoveal Circumscribed Polypoidal Choroidal Vasculopathy and Changes in Imaging Parameters

Diagnostics, 2023
We performed a retrospective, observational study of 51 eyes in 51 treatment-naïve patients with polypoidal choroidal vasculopathy (PCV), whose lesion ranged within the 6 × 6 mm scope of optical coherence tomography angiography (OCTA).
Fan Xia, Peiyu Xing, Hao Zhang, Tongtong Niu, Qi Wang, Rui Hua   +5 more
doaj   +1 more source

Predictive biomarkers of age-related macular degeneration response to anti-VEGF treatment [PDF]

, 2021
Age-related macular degeneration (AMD) is an incurable disease associated with aging that destroys sharp and central vision. Increasing evidence implicates both systemic and local inflammation in the pathogenesis of AMD.
Ochoa, Rodrigo, Larráyoz, Ignacio M. [0000-0003-1629-152X], Rodrigo Ochoa, Rafael Peláez, Velilla, Sara, Álvaro Pérez-Sala, Ana I. Oca, Sara Velilla, Peláez, Rafael [0000-0002-4047-6017], Ana Pariente, Ignacio M. Larráyoz, Oca, Ana I., Pérez-Sala, Álvaro, Pariente, Ana   +13 more
core   +1 more source

Biomarkers as Predictive Factors of Anti-VEGF Response [PDF]

, 2022
Age-related macular degeneration is the main cause of irreversible vision in developed countries, and intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections are the current gold standard treatment today.
Bobadilla, Miriam, Larráyoz, Ignacio M. [0000-0003-1629-152X], Rafael Peláez, Bobadilla, Miriam [0000-0002-7719-3483], Álvaro Pérez-Sala, Larráyoz, Ignacio M., Ana I. Oca, Miriam Bobadilla, Peláez, Rafael [0000-0002-4047-6017], Ana Pariente, Ignacio M. Larráyoz, Oca, Ana I., Peláez, Rafael, Pérez-Sala, Álvaro, Pariente, Ana   +14 more
core   +1 more source

Complete RPE and outer retinal atrophy in patients receiving anti-VEGF treatment for neovascular age-related macular degeneration.

PLoS ONE, 2020
IMPORTANCE:Neovascular age-related macular degeneration (nAMD) is a leading cause of blindness with several intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents available for its management such as aflibercept, bevacizumab, and ...
Victor A Eng, Nadim Rayess, Huy V Nguyen, Theodore Leng   +3 more
doaj   +1 more source

Anti-VEGF-A antibody does not recognize VEGF-A : Incubation with VEGF-A antibody

, 2011
This antibody recognizes the VEGF-A monomer (22.5 kDa) and dimer (45 kDa) in control and glaucomatous retinas (first two lanes). VEGF-A antibody does not recognize 25 ng, 100 ng, or 250 ng of VEGF-A recombinant protein in the same membrane (last three ...
Wei Huang (36889), Diane Darland (53480), Arjun Ray (53479), Cynthia L. Grosskreutz (53482), Ceren Ergorul (53478), Zhonghui K. Luo (53481)   +5 more
core   +1 more source

Shows Kaplan Meier Survival table analysis overall, anti-VEGF, and number of injections groups.

, 2022
Shows Kaplan Meier Survival table analysis overall, anti-VEGF, and number of injections groups.
Rajiv Raman (201470), Pavan Verkicharla (13132970), Priya Jana (13132967), Jay Chhablani (561257), Mukesh Jain (14880), Ashik Mohamed (3043896), Anthony Vipin Das (8856230), Raja Narayanan (13132964), Srikanta Kumar Padhy (13132973)   +8 more
core   +1 more source

UiO‐66 metal–organic frameworks in biomedicine: From structural tunability to bioimaging, photodiagnostics, and photodynamic cancer therapy

FEBS Open Bio, EarlyView.
UiO‐66(Zr) metal–organic frameworks are chemically stable, biocompatible, and highly tunable nanomaterials. Their modular structure enables controlled drug delivery, multimodal bioimaging, and light‐activated photodynamic therapy, supporting integrated diagnostic and therapeutic (theranostic) applications in cancer and biomedical research.
Veronika Huntošová, Grigorii Rakhalskii, Miroslav Almáši   +2 more
wiley   +1 more source

Assessment of mouse VEGF neutralization by ranibizumab and aflibercept.

PLoS ONE, 2022
PurposeTo assess the interaction between ranibizumab, aflibercept, and mouse vascular endothelial growth factor (VEGF), both in vivo and in vitro.MethodsIn vivo, the effect of intravitreal injection of ranibizumab and aflibercept on oxygen induced ...
Yusuke Ichiyama, Riko Matsumoto, Shumpei Obata, Osamu Sawada, Yoshitsugu Saishin, Masashi Kakinoki, Tomoko Sawada, Masahito Ohji   +7 more
doaj   +1 more source